| [1] |
Xu X, Nie S, Liu Z, et al. Epidemiology and clinical correlates of AKI in Chinese hospitalized adults [J]. Clin J Am Soc Nephrol, 2015, 10(9): 1510-1518.
|
| [2] |
Lei J, Xie Y, Sheng J, et al. Intestinal microbiota dysbiosis in acute kidney injury: novel insights into mechanisms and promising therapeutic strategies [J]. Ren Fail, 2022, 44(1): 571-580.
|
| [3] |
Gong J, Noel S, Pluznick JL, et al. Gut microbiota-kidney cross-talk in acute kidney injury [J]. Semin Nephrol, 2019, 39(1): 107-116.
|
| [4] |
Kim CH, Moon SJ. The role of the gut microbiota in acute kidney injury: a new therapeutic candidate? [J]. Kidney Res Clin Pract, 2021, 40(4): 505-507.
|
| [5] |
Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body [J]. PLoS Biol, 2016, 14(8): e1002533.
|
| [6] |
Gilbert JA, Blaser MJ, Caporaso JG, et al. Current understanding of the human microbiome [J]. Nat Med, 2018, 24(4): 392-400.
|
| [7] |
Markowiak-Kopec P, Slizewska K. The effect of probiotics on the production of short-chain fatty acids by human intestinal microbiome [J]. Nutrients, 2020, 12(4): 1107.
|
| [8] |
Haber AL, Biton M, Rogel N, et al. A single-cell survey of the small intestinal epithelium [J]. Nature, 2017, 551(7680): 333-339.
|
| [9] |
Emal D, Rampanelli E, Stroo I, et al. Depletion of gut microbiota protects against renal ischemia-reperfusion injury [J]. J Am Soc Nephrol, 2017, 28(5): 1450-1461.
|
| [10] |
Moghadamrad S, Mccoy KD, Geuking MB, et al. Attenuated portal hypertension in germ-free mice: function of bacterial flora on the development of mesenteric lymphatic and blood vessels [J]. Hepatology, 2015, 61(5): 1685-1695.
|
| [11] |
Andrianova NV, Popkov VA, Klimenko NS, et al. Microbiome-metabolome signature of acute kidney injury [J]. Metabolites, 2020, 10(4): 142.
|
| [12] |
Liu Y, Li YJ, Loh YW, et al. Fiber derived microbial metabolites prevent acute kidney injury through G-protein coupled receptors and HDAC inhibition [J]. Front Cell Dev Biol, 2021, 9: 648639.
|
| [13] |
Lee TH, Park D, Kim YJ, et al. Lactobacillus salivarius BP121 prevents cisplatin induced acute kidney injury by inhibition of uremic toxins such as indoxyl sulfate and p-cresol sulfate via alleviating dysbiosis [J]. Int J Mol Med, 2020, 45(4): 1130-1140.
|
| [14] |
Gharaie S, Noel S, Rabb H. Gut microbiome and AKI: roles of the immune system and short-chain fatty acids [J]. Nephron, 2020, 144(12): 662-664.
|
| [15] |
Yang J, Kim CJ, Go YS, et al. Intestinal microbiota control acute kidney injury severity by immune modulation [J]. Kidney Int, 2020, 98(4): 932-946.
|
| [16] |
Veldeman L, Vanmassenhove J, Van Biesen W, et al. Evolution of protein-bound uremic toxins indoxyl sulphate and p-cresyl sulphate in acute kidney injury [J]. Int Urol Nephrol, 2019, 51(2): 293-302.
|
| [17] |
Fang Q, Liu N, Zheng B, et al. Roles of gut microbial metabolites in diabetic kidney disease [J]. Front Endocrinol (Lausanne), 2021, 12: 636175.
|
| [18] |
Li J, Moturi KR, Wang L, et al. Gut derived-endotoxin contributes to inflammation in severe ischemic acute kidney injury [J]. BMC Nephrol, 2019, 20(1): 16.
|
| [19] |
Chassaing B, Kumar M, Baker MT, et al. Mammalian gut immunity [J]. Biomed J, 2014, 37(5): 246-258.
|
| [20] |
Nakade Y, Iwata Y, Furuichi K, et al. Gut microbiota-derived D-serine protects against acute kidney injury [J]. JCI Insight, 2018, 3(20): e97957.
|
| [21] |
Osada Y, Nakagawa S, Ishibe K, et al. Antibiotic-induced microbiome depletion alters renal glucose metabolism and exacerbates renal injury after ischemia-reperfusion injury in mice [J]. Am J Physiol Renal Physiol, 2021, 321(4): F455-F465.
|
| [22] |
Hsu CN, Tain YL. Chronic kidney disease and gut microbiota: what is their connection in early life? [J]. Int J Mol Sci, 2022, 23(7): 3954.
|
| [23] |
Zheng DW, Pan P, Chen KW, et al. An orally delivered microbial cocktail for the removal of nitrogenous metabolic waste in animal models of kidney failure [J]. Nat Biomed Eng, 2020, 4(9): 853-862.
|
| [24] |
Wang Y, Wu Y, Wang Y, et al. Antioxidant properties of probiotic bacteria [J]. Nutrients, 2017, 9(5): 521.
|
| [25] |
Yang J, Ji GE, Park MS, et al. Probiotics partially attenuate the severity of acute kidney injury through an immunomodulatory effect [J]. Kidney Res Clin Pract, 2021, 40(4): 620-633.
|
| [26] |
Sarwar S, Hossain MJ, Irfan NM, et al. Renoprotection of selected antioxidant-rich foods (water spinach and red grape) and probiotics in gentamicin-induced nephrotoxicity and oxidative stress in rats [J]. Life (Basel), 2022, 12(1): 60.
|
| [27] |
Canfora EE, Meex R, Venema K, et al. Gut microbial metabolites in obesity, NAFLD and T2DM [J]. Nat Rev Endocrinol, 2019, 15(5): 261-273.
|
| [28] |
Peng Q, Zeng XF, Zhu JL, et al. Effects of dietary Lactobacillus plantarum B1 on growth performance, intestinal microbiota, and short chain fatty acid profiles in broiler chickens [J]. Poult Sci, 2016, 95(4): 893-900.
|
| [29] |
Huang W, Zhou L, Guo H, et al. The role of short-chain fatty acids in kidney injury induced by gut-derived inflammatory response [J]. Metabolism, 2017, 68: 20-30.
|
| [30] |
Sun Y, Zhou C, Chen Y, et al. Quantitative increase in short-chain fatty acids, especially butyrate protects kidney from ischemia/reperfusion injury [J]. J Investig Med, 2022, 70(1): 29-35.
|
| [31] |
Hsu CN, Hou CY, Chang CI, et al. Resveratrol butyrate ester protects adenine-treated rats against hypertension and kidney disease by regulating the gut-kidney axis [J]. Antioxidants (Basel), 2021, 11(1): 83.
|
| [32] |
Knauf F, Brewer JR, Flavell RA. Immunity, microbiota and kidney disease [J]. Nat Rev Nephrol, 2019, 15(5): 263-274.
|
| [33] |
Du Y, Tang G, Yuan W. Suppression of HDAC2 by sodium butyrate alleviates apoptosis of kidney cells in db/db mice and HG-induced NRK-52E cells [J]. Int J Mol Med, 2020, 45(1): 210-222.
|
| [34] |
Andrade-Oliveira V, Amano MT, Correa-Costa M, et al. Gut bacteria products prevent AKI induced by ischemia-reperfusion [J]. J Am Soc Nephrol, 2015, 26(8): 1877-1888.
|
| [35] |
Lin MY, de Zoete MR, van Putten JP, et al. Redirection of epithelial immune responses by short-chain fatty acids through inhibition of histone deacetylases [J]. Front Immunol, 2015, 6: 554.
|
| [36] |
Foresto-Neto O, Ghirotto B, Camara NOS. Renal sensing of bacterial metabolites in the gut-kidney axis [J]. Kidney360, 2021, 2(9): 1501-1509.
|
| [37] |
Sasabe J, Miyoshi Y, Rakoff-Nahoum S, et al. Interplay between microbial d-amino acids and host d-amino acid oxidase modifies murine mucosal defence and gut microbiota [J]. Nat Microbiol, 2016, 1(10): 16125.
|
| [38] |
Okada A, Nangaku M, Jao TM, et al. D-serine, a novel uremic toxin, induces senescence in human renal tubular cells via GCN2 activation [J]. Sci Rep, 2017, 7(1): 11168.
|
| [39] |
Al KS, Reichert B, Shatat IF. The microbiome and blood pressure: can microbes regulate our blood pressure? [J]. Front Pediatr, 2017, 5: 138.
|
| [40] |
Li T, Zhao J, Miao S, et al. Protective effect of H2S on LPS-induced AKI by promoting autophagy [J]. Mol Med Rep, 2022, 25(3): 96.
|
| [41] |
Rund KM, Peng S, Greite R, et al. Dietary omega-3 PUFA improved tubular function after ischemia induced acute kidney injury in mice but did not attenuate impairment of renal function [J]. Prostaglandins Other Lipid Mediat, 2020, 146: 106386.
|
| [42] |
Vandeputte D, Falony G, Vieira-Silva S, et al. Prebiotic inulin-type fructans induce specific changes in the human gut microbiota [J]. Gut, 2017, 66(11): 1968-1974.
|
| [43] |
Cammarota G, Ianiro G, Tilg H, et al. European consensus conference on faecal microbiota transplantation in clinical practice [J]. Gut, 2017, 66(4): 569-580.
|
| [44] |
Barba C, Soulage CO, Caggiano G, et al. Effects of fecal microbiota transplantation on composition in mice with CKD [J]. Toxins (Basel), 2020, 12(12): 741.
|
| [45] |
Lauriero G, Abbad L, Vacca M, et al. Fecal microbiota transplantation modulates renal phenotype in the humanized mouse model of IgA nephropathy [J]. Front Immunol, 2021, 12: 694787.
|
| [46] |
Lano G, Burtey S, Sallee M. Indoxyl sulfate, a uremic endotheliotoxin [J]. Toxins (Basel), 2020, 12(4): 229.
|
| [47] |
Sun J, Luo JW, Yao WJ, et al. Effect of emodin on gut microbiota of rats with acute kidney failure [J]. Zhongguo Zhong Yao Za Zhi, 2019, 44(4): 758-764.
|